ARROWHEAD PHARMACEUTICALS, INC. Insider Trading for February 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARROWHEAD PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ARROWHEAD PHARMACEUTICALS, INC. for February 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 12 2014 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | CFO | Option Exercise | M | 2.01 | 16,000 | 32,160 | 312,000 | |
| Feb 12 2014 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | CFO | Sell | S | 18.77 | 16,000 | 300,290 | 71,500 | 87.5 K to 71.5 K (-18.29 %) |
| Feb 12 2014 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | CFO | Buy | M | 2.01 | 16,000 | 32,160 | 87,500 | 71.5 K to 87.5 K (+22.38 %) |
| Feb 10 2014 | ARWR | ARROWHEAD PHARMACE ... | FRYKMAN EDWARD W | Director | Option Exercise | M | 10.00 | 5,000 | 50,000 | 77,500 | |
| Feb 10 2014 | ARWR | ARROWHEAD PHARMACE ... | FRYKMAN EDWARD W | Director | Sell | S | 15.98 | 3,148 | 50,296 | 23,852 | 27 K to 23.9 K (-11.66 %) |
| Feb 10 2014 | ARWR | ARROWHEAD PHARMACE ... | FRYKMAN EDWARD W | Director | Buy | M | 10.00 | 5,000 | 50,000 | 27,000 | 22 K to 27 K (+22.73 %) |
| Feb 10 2014 | ARWR | ARROWHEAD PHARMACE ... | FRYKMAN EDWARD W | Director | Grant | A | 0.00 | 15,000 | 0 | 22,000 | 7 K to 22 K (+214.29 %) |
| Feb 10 2014 | ARWR | ARROWHEAD PHARMACE ... | PERRY MICHAEL S | Director | Grant | A | 0.00 | 15,000 | 0 | 15,000 | 0 to 15 K |
| Feb 10 2014 | ARWR | ARROWHEAD PHARMACE ... | McKenney Charles | Director | Grant | A | 0.00 | 15,000 | 0 | 17,220 | 2.2 K to 17.2 K (+675.68 %) |
| Feb 10 2014 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
| Feb 10 2014 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Option Exercise | A | 14.54 | 50,000 | 727,000 | 436,000 | |
| Feb 10 2014 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Grant | A | 0.00 | 125,000 | 0 | 125,000 | 0 to 125 K |
| Feb 10 2014 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | President and CEO | Option Exercise | A | 14.54 | 60,000 | 872,400 | 786,466 | |
| Feb 10 2014 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | President and CEO | Grant | A | 0.00 | 210,000 | 0 | 244,173 | 34.2 K to 244.2 K (+614.52 %) |
| Feb 10 2014 | ARWR | ARROWHEAD PHARMACE ... | Lewis David L. | Chief Scientific Of ... | Option Exercise | A | 14.54 | 120,000 | 1,744,800 | 317,500 | |
| Feb 10 2014 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | CFO | Option Exercise | A | 14.54 | 50,000 | 727,000 | 328,000 | |
| Feb 10 2014 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | CFO | Grant | A | 0.00 | 70,000 | 0 | 71,500 | 1.5 K to 71.5 K (+4,666.67 %) |